Rituximab not superior to conventional strategy for eosinophilic granulomatosis with polyangiitis

In recent years, doctors and scientists are increasingly studying long-lasting illnesses that begin after someone recovers from an infection. Two of the most well-known examples are long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Can simple words like "and" or "then" in online reviews help health care providers learn about their patients' experiences?

The federal government's Medicare program and older adults together spend $4.4 billion a year on care that has low clinical value for patients and can even raise their risk of harm, a new study finds.

A recent multicenter clinical trial has uncovered inflammatory pathways that contribute to asthma flare-ups in children that occur despite treatment, according to findings published in JAMA Pediatrics.

US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million pound battle against US rival Moderna over the COVID-19 vaccine.

A baby boy born last week to an Ohio couple developed from an embryo that had been frozen for more than 30 years in what is believed to be the longest storage time before a birth.

In a discovery that could guide the development of next-generation antidepressants and antipsychotic medications, researchers at the Icahn School of Medicine at Mount Sinai have developed new insights into how a critical brain receptor works at the molecular level and why that matters for mental health treatments.

Researchers have discovered a protein which is critical for steering melanoma cancer cells as they spread throughout the body. The malignant cells become dependent on this protein to migrate, pointing to new strategies for impeding metastasis.

Rheumatoid arthritis (RA) is a chronic autoimmune disease in which the immune system mistakenly attacks the lining of the joints (the synovium), causing pain, swelling, and progressive damage. Approximately 18 million people worldwide live with RA. Early diagnosis and treatment can relieve symptoms, slow disease progression, and help prevent disability.

People with diabetes suffer from depression more frequently than average. Researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim (Forschungsinstitut an der Diabetes Akademie Mergentheim, FIDAM) and the German Center for Diabetes Research (DZD) were able to show in a large-scale analysis that biomarkers for chronic inflammation levels influence the therapeutic success of depressive symptoms—however, with considerable differences in type 1 and type 2 diabetes. The findings could help to customize the treatment of depression in people with diabetes in the future.

President Donald Trump has introduced a new effort to help Americans more easily share their health records with doctors, using new technology and artificial intelligence (AI) tools.

The earliest warning signs of multiple sclerosis (MS) may emerge more than a decade before the first classical neurological symptoms occur, according to new research from the University of British Columbia.

A paper published in Cell highlights how researchers have leveraged AI-based computational protein design to create a novel synthetic ligand that activates the Notch signaling pathway, a key driver in T-cell development and function.

Medicare drug plans are increasingly excluding coverage of new specialty drugs that treat complex conditions like cancers and autoimmune diseases. New research from the USC Schaeffer Center shows how these barriers may come at a cost to patients' health.

A sudden surge of chikungunya cases has been reported in Foshan city in China, increasing from 478 cases to almost 3,000 cases within a week, according to South China Morning Post.

Less radiation exposure during diagnosis and treatment for breast and lung cancer: new Fraunhofer method combines X-ray imaging and radar.

A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard. This research, published in the July issue of The Journal of Nuclear Medicine, lays the foundation for further development of radionuclide therapies targeting CSCs, offering renewed hope for more effective treatment options and improved outcomes for patients.

A new Stanford-led study sheds light on "an emerging psychological health crisis" that disproportionately affects girls. Published July 30 in The Lancet Planetary Health, the study is among the first to quantify how repeated climate stressors impact the psychological well-being and future outlook of adolescents in low-resource settings.